Microrobots could be precisely directed, under clinical conditions, by integrating systems for navigation, therapeutic ...

CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.

Editing genes in sperm, eggs and embryos is currently banned in the United States. The current effort by Preventive, a Silicon Valley startup, involves a couple with a genetic abnormality who want to ...

What would it take to live on a world orbiting another star? Scientists now believe Proxima B could host the first human ...

Trump Signs Spending Bill, Ending Longest Shutdown in U.S. History A Pennsylvania sheriff struck a deal with ICE. Months ...

As Earth's climate warms and changes, sustainable agricultural practices are critical for feeding a rapidly growing population. Can we genetically engineer crops to adapt to drought and other effects ...

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered ...

Access to ERS Genomics’ foundational CRISPR/Cas9 patent portfolio expands our genetic engineering toolkit and strengthens our ability to speed up and optimize strain development across Dyadic’s ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...